Novartis Investigative site

Garmisch-Partenkirch

0 studies enrolling now · 1 studies all time

What they study most

Systemic Juvenile Idiopathic Arthritis

Studies at this site

• Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) — Stopped early